走進魯銀
  魯銀標識
  企業概況
  企業歷程
  企業榮譽
  所處位置: 詳細信息
     
 
奧勃蘭參考文獻

錄入時間:2012-12-29 16:58:10   點擊次數:9352  
【英文文獻】
[1] Tárnok K, Kiss E, Luiten PG, Nyakas C, Tihanyi K, Schlett K, Eisel UL. Effects of Vinpocetine on mitochondrial function and   neuroprotection in primary cortical neurons. Neurochem Int. 2008 Dec;53(6-8):289-95. Epub 2008 Aug 28.
[2] Vas A, Shchukin Y, Karrenbauer VD, Cselényi Z, Kostulas K, Hillert J, Savic I, Takano A, Halldin C, Gulyás B. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients. J Neurol Sci. 2008 Jan 15;264(1-2):9-17. Epub 2007 Aug 28.
[3] Lendvai B, Zelles T, Rozsa B, Vizi ES. A vinca alkaloid enhances morphological dynamics of dendritic spines of neocortical layer 2/3 pyramidal cells. Brain Res Bull. 2003 Jan 15;59(4):257-60.
[4] Jucker M, Bättig K, Meier-Ruge W. Effects of aging and vincamine derivatives on pericapillary microenvironment: stereological characterization of the cerebral capillary network. Neurobiol Aging. 1990 Jan-Feb;11(1):39-46.
[5] Jucker M, Meier-Ruge W. Effects of brovincamine on stereological capillary parameters in adult and old Fischer-344 rats. Microvasc Res. 1989 May;37(3):298-307.
[6] Juan YP, Tsai TH. Measurement and pharmacokinetics of vincamine in rat blood and brain using microdialysis. J Chromatogr A. 2005 Sep 23;1088(1-2):146-51.
[7] Hagstadius S, Gustafson L, Risberg J.The effects of bromvincamine and vincamine on regional cerebral blood flow and mental functions in patients with multi-infarct dementia. Psychopharmacology (Berl). 1984;83(4):321-6.
[8] Fischhof PK, Möslinger-Gehmayr R, Herrmann WM, Friedmann A, Russmann DL.Therapeutic efficacy of vincamine in dementia. Neuropsychobiology. 1996;34(1):29-35.
[9] Fayed AH. Brain trace element concentration of rats treated with the plant alkaloid, vincamine. Biol Trace Elem Res. 2010 Sep;136(3):314-9. Epub 2009 Nov 10.
[10] Vas A, Gulyás B. Eburnamine derivatives and the brain. Med Res Rev. 2005 Nov;25(6):737-57.
[11] Ilkay Orhan, Qamar Naz,Murat Kartal, Fatma Tosum, Bilge Sener, and M.Iqbal Choudhary. In vitro Anticholinesterase Activity of Various Alkaloids. Z. Naturforsch,62c,684-688(2007).
[12] Juan YP, Tsai TH. Measurement and pharmacokinetics of vincamine in rat blood and brain using microdialysis. J Chromatogr A. 2005 Sep 23;1088(1-2):146-51.
[13] Vereczkey L, Tamas G, Szporny L. Metabolism of vincamine in the rat in vivo and in vitro. Drug Res. 30(11). Nr.11(1980)
[14] Martucci N, Manna V, Agnoli A. Pharmaco-EEG study on vincamine and on teproside in patients with chronic cerebrovascular disease. Int J Clin Pharmacol Res. 1984;4(4):291-302.
[15] Vereczkey L. Pharmacokinetics and metabolism of vincamine and related compounds. Eur J Drug Metab Pharmacokinet. 1985 Apr-Jun;10(2):89-103.
[16] Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S.Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure. J Glaucoma. 1999 Apr;8(2):117-23.
[17] Sawada A, Kitazawa Y, Yamamoto T, Okabe I, Ichien K. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology. 1996 Feb;103(2):283-8.
[18] Erdo SA, Molnár P, Lakics V, Bence JZ, Tömösközi Z. Vincamine and vincanol are potent blockers of voltage-gated Na+ channels. Eur J Pharmacol. 1996 Oct 24;314(1-2):69-73.
[19] Gulyás B, Halldin C, Vas A, Banati RB, Shchukin E, Finnema S, Tarkainen J, Tihanyi K, Szilágyi G, Farde L. [11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies. J Neurol Sci. 2005 Mar 15;229-230:219-23. Epub 2004 Dec 16.
【中文文獻】
[1] 郭梅,徐一峰. 阿樸長春胺酸乙酯治療Alzheimer型癡呆和多發梗塞性癡呆及血流變學分析. 上海醫科大學學報. 1995 5(22): 391-393.
[2] 于群濤,于天霞,王英等.奧勃蘭治療慢性缺血性腦血管病的臨床觀察[J].實用心腦肺血管病雜志,2004,12(6):333-334,332.
[3]曾存芝,周增杰.奧勃蘭治療腦梗死100例臨床觀察[J].實用中醫藥雜志,2004,20(11):646-647.
[4] 羅四維,李東升.奧勃蘭治療主觀性耳鳴的臨床觀察[J].聽力學及言語疾病雜志,2010,18(6):601-602.
[5] 遲海濤,金蕊.長春胺緩釋膠囊治療血管性認知功能障礙:與尼莫地平的對照[J].中國組織工程研究與臨床康復,2009,13(47):9369-9372.
[6] 匡良洪,肖勝,肖勁松等.長春胺緩釋膠囊對卒中后抑郁和神經功能恢復的作用觀察[J].中國基層醫藥,2011,18(18):2471-2473.
[7] 馬文娟.長春胺緩釋膠囊治療53例慢性腦供血不足的療效觀察[J].中國民康醫學,2011,23(3):297-327.
[8] 劉艷,張倩,黃丹琳等.長春胺對原發性缺血性視神經視網膜脈絡膜病變療效觀察[J].臨床軍醫雜志,2008,36(2):231-232.
[9] 侯恩太,李多偉.小蔓長春花中長春胺藥學研究進展[J].西北藥學雜志,2010,25(4):314-316.
[10] 段煉,潘愛萍.長春胺治療老年癡呆癥的臨床觀察和療效[J].陜西中醫學院學報,2005,28(5):19-20.
[11] 李敏,張廣東,黃衛華等.長春胺治療腦梗死患者運動及認知功能的臨床研究[J].中原醫刊,2007,34(9):43-44.
[12] 安麗榮,孫超,魏廣寬等.舒血寧聯用長春胺治療椎基動脈系統供血不全40例療效觀察[J].黑龍江醫學,2012,36(4):282-283,311.
[13] 張倩,劉艷,夏江南等.復方樟柳堿聯合長春胺治療原發性缺血性視神經視網膜脈絡膜病變療效觀察[J].醫學新知雜志,2012,22(1):34-35.
[14] 邢蕾,于春俠,于華,刁文杰,張杰. 小蔓長春花生物堿長春胺治療缺血性腦血管疾病的研究進展回顧. 上海中醫藥雜志,2013年,第5期
[15] 任騫,張杰. 小蔓長春花生物堿長春胺及其類似物藥理作用機制研究進展. 中草藥,2013年,已錄用
 
   
 
版權所有:煙臺魯銀藥業有限公司   制作維護:煙臺一搜